关注
Lisa Horvath
Lisa Horvath
University of Sydney
在 lh.org.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
12332019
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
7992018
Frequent loss of estrogen receptor-β expression in prostate cancer
LG Horvath, SM Henshall, CS Lee, DR Head, DI Quinn, S Makela, ...
Cancer research 61 (14), 5331-5335, 2001
4212001
FAK signaling in human cancer as a target for therapeutics
BY Lee, P Timpson, LG Horvath, RJ Daly
Pharmacology & therapeutics 146, 132-149, 2015
4082015
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ...
Nature genetics 53 (1), 65-75, 2021
3312021
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
WA Cooper, T Tran, RE Vilain, J Madore, CI Selinger, M Kohonen-Corish, ...
Lung cancer 89 (2), 181-188, 2015
3222015
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study
SJ Lubner, MR Mahoney, JL Kolesar, NK LoConte, GP Kim, HC Pitot, ...
Journal of Clinical Oncology 28 (21), 3491, 2010
3152010
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse
SM Henshall, DEH Afar, J Hiller, LG Horvath, DI Quinn, KK Rasiah, K Gish, ...
Cancer research 63 (14), 4196-4203, 2003
2932003
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ...
Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010
1922010
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
The Lancet Neurology 17 (12), 1053-1060, 2018
1862018
Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen …
L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ...
Journal of Nuclear Medicine 60 (7), 950-954, 2019
1792019
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridization
CI Selinger, TM Rogers, PA Russell, S O'toole, PY Yip, GM Wright, ...
Modern pathology 26 (12), 1545-1553, 2013
1722013
Results of a prospective phase 2 pilot trial of 177Lu–PSMA-617 therapy for metastatic castration-resistant prostate cancer including imaging predictors of treatment response …
L Emmett, M Crumbaker, B Ho, K Willowson, P Eu, L Ratnayake, ...
Clinical genitourinary cancer 17 (1), 15-22, 2019
1662019
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
HM Lin, L Castillo, KL Mahon, K Chiam, BY Lee, Q Nguyen, MJ Boyer, ...
British journal of cancer 110 (10), 2462-2471, 2014
1472014
Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer
Y Zeng, K Opeskin, ME Baldwin, LG Horvath, MG Achen, SA Stacker, ...
Clinical cancer research 10 (15), 5137-5144, 2004
1472004
Circulating microRNAs predict biochemical recurrence in prostate cancer patients
LA Selth, SL Townley, AG Bert, PD Stricker, PD Sutherland, LG Horvath, ...
British journal of cancer 109 (3), 641-650, 2013
1432013
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer
SM Henshall, DEH Afar, KK Rasiah, LG Horvath, K Gish, I Caras, ...
Oncogene 22 (38), 6005-6012, 2003
1332003
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling
L Zhao, BY Lee, DA Brown, MP Molloy, GM Marx, N Pavlakis, MJ Boyer, ...
Cancer research 69 (19), 7696-7703, 2009
1312009
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression
LG Horvath, SM Henshall, JG Kench, JJ Turner, D Golovsky, PC Brenner, ...
The Prostate 59 (3), 234-242, 2004
1312004
ERG induces taxane resistance in castration-resistant prostate cancer
G Galletti, A Matov, H Beltran, J Fontugne, J Miguel Mosquera, C Cheung, ...
Nature communications 5 (1), 5548, 2014
1282014
系统目前无法执行此操作,请稍后再试。
文章 1–20